Dignitana AB Publishes Q1 2021 Interim Report
Reopening and reimbursement progress Financial highlights Q1 2021 ·Net sales amounted to 13,2 MSEK (11,4), an increase of 16 percent over the same period 2020 · Operating result amounted to -7,1 MSEK (-12,5) · Net result after financial items amounted to -7,7 MSEK (-12,8) · Earnings per share was -0,12 SEK (-0,23) · Cash Balance amounted to 44,4 MSEK (8,8) · Average Daily Treatment Revenue (ADTR)* was 130 TSEK (118), an increase of 10 percent over the same period in 2020 Significant events during the period ·The Extraordinary General Meeting on